AbbVie Biotherapeutics Inc.;Dana-Farber Cancer Institute
发明人:
申请号:
EP13168364.1
公开号:
EP2641600A1
申请日:
2007.08.07
申请国别(地区):
EP
年份:
2013
代理人:
摘要:
Composition suitable for treating multiple myeloma in a subject, comprising a therapeutically effective amount of HuLuc63, a therapeutically effective amount of lenalidomide and/or bortezomib, and a pharmaceutically acceptable carrier, wherein said composition is capable of being administered in a single or multiple dose regimen.